Cargando…

Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion

BACKGROUND: Mutant TP53 interacts with other proteins to produce gain-of-function properties that contribute to cancer metastasis. However, the underlying mechanisms are still not fully understood. METHODS: Using immunoprecipitation and proximity ligation assays, we evaluated breast cancer anti-estr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Alvin Kunyao, Itahana, Yoko, Seshachalam, Veerabrahma Pratap, Chow, Hui Ying, Ghosh, Sujoy, Itahana, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782524/ https://www.ncbi.nlm.nih.gov/pubmed/33144694 http://dx.doi.org/10.1038/s41416-020-01124-9

Ejemplares similares

Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation
por: Yeo, Shi Yun, et al.
Publicado: (2016)

Emerging Roles of p53 Family Members in Glucose Metabolism
por: Itahana, Yoko, et al.
Publicado: (2018)

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction
por: Clegg, Hilary V., et al.
Publicado: (2012)

miR-141, a new player, joins the senescence orchestra
por: Itahana, Yoko, et al.
Publicado: (2013)

ABCB1 protects bat cells from DNA damage induced by genotoxic compounds
por: Koh, Javier, et al.
Publicado: (2019)

Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells
por: Itahana, Yoko, et al.
Publicado: (2016)

Radiation therapy and cancer control in developing countries: Can we save more lives?
por: Baskar, Rajamanickam, et al.
Publicado: (2017)

Critical role of the BAF chromatin remodeling complex during murine neural crest development
por: Bi-Lin, Kathleen Wung, et al.
Publicado: (2021)

pRb or its cousins: Who controls the family business?
por: Itahana, Koji, et al.
Publicado: (2012)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

p53 upregulates PLCε-IP3-Ca(2+) pathway and inhibits autophagy through its target gene Rap2B
por: Di, Jiehui, et al.
Publicado: (2017)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

p32 heterozygosity protects against age- and diet-induced obesity by increasing energy expenditure
por: Liu, Yong, et al.
Publicado: (2017)

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
por: Yang, Chang, et al.
Publicado: (2021)

BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance
por: Cai, Zhiping, et al.
Publicado: (2018)

Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
por: Na, Bing, et al.
Publicado: (2019)

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
por: Abrams, Stephen L., et al.
Publicado: (2022)

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
por: Sallman, David A., et al.
Publicado: (2021)

NEK2, a promising target in TP53 mutant cancer
por: Cusan, Martina, et al.
Publicado: (2022)

Mutant TP53 driving the Warburg Effect in Mantle Cell lymphoma
por: Kliebhan, Johannes, et al.
Publicado: (2022)

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
por: Kim, Jin-Ah, et al.
Publicado: (2023)

Role of BCAR4 in prostate cancer cell autophagy
por: Cai, Zhiping, et al.
Publicado: (2021)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival()
por: Mullany, Lisa K., et al.
Publicado: (2015)

Maspin subcellular expression in wild-type and mutant TP53 gastric cancers
por: Gurzu, Simona, et al.
Publicado: (2020)

Ascorbate Inhibits Proliferation and Promotes Myeloid Differentiation in TP53-Mutant Leukemia
por: Smith-Díaz, Carlos C., et al.
Publicado: (2021)

Identification of Novel Characteristics in TP53-Mutant Hepatocellular Carcinoma Using Bioinformatics
por: Yang, Yang, et al.
Publicado: (2022)

Molecular profiling identifies distinct subtypes across TP53 mutant tumors
por: Chen, Xin, et al.
Publicado: (2022)

Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma
por: Luo, Ming, et al.
Publicado: (2023)

BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma
por: Mao, Chun-Guo, et al.
Publicado: (2021)

Haploinsufficiency Interactions of RALBP1 and TP53 in Carcinogenesis
por: Awasthi, Sanjay
Publicado: (2021)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Comparison of Modules of Wild Type and Mutant Huntingtin and TP53 Protein Interaction Networks: Implications in Biological Processes and Functions
por: Basu, Mahashweta, et al.
Publicado: (2013)

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
por: Kancherla, Venkatesh, et al.
Publicado: (2018)

Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2018)

Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency
por: Cole, Alexander J., et al.
Publicado: (2017)

TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology
por: Patel, Shyam A., et al.
Publicado: (2022)

Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine
por: Palomar-Siles, Mireia, et al.
Publicado: (2022)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

S127: DELTATP73 IMPOSES TP53 MUTANT-LIKE PHENOTYPES INCLUDING DRUG RESISTANCE AND POOR PROGNOSIS ON TP53-WILD TYPE ACUTE MYELOID LEUKEMIA.
por: Pereira-Martins, Diego A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h45e1a9td8b6qgthd5ktjckso6